Reports related to this article:
Project(s): View 1 related project in PECWeb
Plant(s): View 1 related plant in PECWeb
Released February 01, 2019 | SUGAR LAND
en
The global market for blood plasma derivatives is expected to show strong growth through 2023. Plasma is a substance in blood that contains blood cells and protein responsible for blood clotting. Plasma derivatives are obtained from specific plasma proteins by the process of fractionation and purification. The derivatives are then solvent detergent-treated or heat-treated to kill certain viruses.
Grifols S.A. (Barcelona, Spain), a global leader in the production of blood plasma-based products, has started construction on "Building 640" in Clayton, North Carolina, which will be equipped for the purification of plasma-derived intravenous immunoglobulin (IVIG). It is designed to have a capacity of between 25 million and 30 million grams per year of IVIG.
Grifols S.A. (Barcelona, Spain), a global leader in the production of blood plasma-based products, has started construction on "Building 640" in Clayton, North Carolina, which will be equipped for the purification of plasma-derived intravenous immunoglobulin (IVIG). It is designed to have a capacity of between 25 million and 30 million grams per year of IVIG.
